Ben Stevens
Ben is the editor of Business of Cannabis. Since 2021, he has researched, written, and published the vast majority of the outlet’s content, delivering agenda-setting journalism on regulation, business strategy, and policy across Europe.
Ben Stevens · page 142
- CBD Market
Love Hemp Reveals 16% Drop In Revenues Amid First Financial Update Since Shares Were Suspended
LOVE Hemp has issued its first financial update to investors since its stock was suspended on the Aquis Stock Exchange nearly three months ago.
- News
Stenocare Plans To Get ‘Even More Aggressive’ In Expansion Ambitions As Stock Price Jumps Double Digits
STENOCARE has seen double digit price rises across both the Copenhagen NASDAQ and the Frankfurt Stock Exchange, jumping 17.5% and 10% respectively over the past week.
- Companies
Juicy Fields ‘Bears All The Hallmarks Of The Russian Mafia’ & Is Likely To Have Seen ‘No Less Than €500m’ Lost
THE fallout from the collapse of Juicy Fields has continued to develop at breakneck speed since investors first complained of being unable to access their funds in mid-July.
- Markets & Stocks
European Cannabis Stocks Review: SEED Innovations Says Yooma Wellness Has Had A ‘Major Impact’ On Its NAV & MGC Pharma Announces New $10m Financing Agreement
THIS week saw two landmark cannabis reform bills put before US Congress, including the Cannabis Administration and Opportunity Act (“CAOA”) and the Secure and Fair Enforcement Act (SAFE).
- Adult-Use
Akanda Could Lose Its African Subsidiary Bophelo Amid Dispute With Former Executive Chairman
AKANDA’s wholly owned subsidiary Bophelo Bioscience, which operates the company’s key cultivation facility in Lesotho, has been taken into liquidation by the country’s high court in what the company is calling a ‘retaliation’ from a disgruntled former director.
- News
‘Through Full Transparency’ Modern Technology Can Make A Lot Of Today’s Regulatory Standards Obsolete
THE confluence of hundreds of cannabis industry professionals from over 30 countries at this year’s Cannabis Europa London saw a recurring talking point emerge, the need for a global standardised model for the regulation of cannabis.
- Press releases
All-Party Parliamentary Group For CBD Products Presents Business Plan To Future-Proof UK Cannabis Industry
THE All-Party Parliamentary Group (APPG) for CBD (Cannabidiol) Products, co-chaired by Crispin Blunt MP and Baroness Manzoor CBE, today present a series of recommendations to Her Majesty’s Government in order to create a well-regulated, multi-faceted and competitive UK cannabis industry.
- Pharmaceutical
OCT Says Potential ‘Mergers & Acquisitions Are On The Table’ As It Prepares For Vital Upcoming Fundraise
OXFORD Cannabinoid Technologies (OCT) is gearing up to raise its second major round of funding since it listed on the London Stock Exchange (LSE) last May.
- Companies
Juicy Fields’ Collapse – What We Know So Far
JUICY Fields, a cannabis crowdfunding company offering investors outlandish returns, has collapsed in a characteristically complex and opaque fashion.
- Pharmaceutical
European Cannabis Stocks Review: IM Cannabis Could Be Delisted From NASDAQ, DeepVerge Jumps 40%, & More From OCT & Ananda Developments
IM Cannabis IM Cannabis announced to investors earlier this week that on Wednesday, July 13, it was warned its stocks could soon be removed from the NASDAQ stock exchange unless its stock price rises above $1.
- CBD Market
High Court Challenge Could See Ireland Lift Blanket Ban On CBD Products By October
IRELAND’s restrictive policies on CBD, which all but ban its sale, were challenged in the High Court last week as the industry continues its fight for survival in the country.
- Pharmaceutical
Celadon Pharma Says It Wants To Deliver Its ‘Trial And Product As A Holistic Package’ Overseas Amid First Update Since AIM Listing
Celadon Pharmaceuticals recently released its first substantial business update since becoming the first British cannabis company since GW Pharmaceuticals to list on the Alternative Investments Market (AIM) in March this year.











